Is Kratom Legal in Indiana? State Law and Shipping Guide

Quick answer: kratom is restricted statewide in Indiana.

Indiana law names mitragynine and 7-hydroxymitragynine in the statutory definition of a synthetic drug, and the state's Schedule I statute incorporates synthetic drugs into Schedule I. Because ordinary kratom products naturally contain mitragynine and may contain 7-hydroxymitragynine, consumer possession, sale, and delivery are not available under the statewide framework. Kratom Paradise does not accept orders for Indiana delivery.

What Indiana law says about kratom

Indiana reaches kratom through its controlled-substance code rather than through a statute titled as a kratom ban. The key provisions must be read together. Indiana Code section 35-31.5-2-321 defines "synthetic drug" through a long list of named chemical compounds and related categories. That list expressly includes 7-hydroxymitragynine and mitragynine.

Indiana Code section 35-48-2-4 establishes Schedule I. Subsection (g) incorporates synthetic drugs as defined in section 35-31.5-2-321. The result is that the two named kratom alkaloids sit inside the state's Schedule I framework through the statutory synthetic-drug definition.

The terminology can sound counterintuitive because mitragynine and 7-hydroxymitragynine occur in Mitragyna speciosa. The legal consequence, however, turns on the words Indiana placed in its code. The statute lists the compounds by name and does not create a general retail exception for naturally occurring kratom leaf, traditional powder, capsules, extracts, or tablets.

Indiana's possession statute, section 35-48-4-7, applies when a person knowingly or intentionally possesses a Schedule I controlled substance without valid legal authorization. A basic violation is a Class A misdemeanor, and the statute provides a Level 6 felony classification when an enhancing circumstance applies.

Section 35-48-4-2 addresses manufacture, financing manufacture, delivery, financing delivery, and possession with intent to deliver a Schedule I, II, or III controlled substance. The base dealing offense is a Level 6 felony, with higher felony levels tied to statutory quantity thresholds and enhancing circumstances.

Those penalty provisions matter because a retail shipment is not merely possession by the recipient. It also involves a sale and delivery decision by the sender. Indiana does not provide an ordinary direct-to-consumer kratom exception based on age, package warnings, laboratory testing, low 7-hydroxymitragynine content, or an out-of-state seller's lawful operation elsewhere.

Why ordinary kratom products are affected

Mitragynine is a defining alkaloid of kratom leaf. A product does not need to be promoted as "synthetic kratom" to contain a substance named in section 35-31.5-2-321. Powder, capsules, botanical extracts, and tablets made from kratom commonly contain mitragynine by their nature.

Indiana's Schedule I incorporation also means that the earlier, dedicated synthetic-drug possession and dealing sections are not the only relevant provisions. Sections 35-48-4-10.5 and 35-48-4-11.5 were repealed in 2019, but that repeal did not legalize the named compounds. The general Schedule I dealing and possession statutes now provide the operative offense framework.

There is no statewide adult-use threshold. A purchaser does not become eligible at 18 or 21, and government-issued identification does not authorize an ordinary sale. Indiana has no current kratom retail license that converts consumer possession or delivery into a lawful transaction.

How Indiana's statewide restriction developed

• 2012Public Law 114-2012 added Indiana Code section 35-31.5-2-321. The statutory source history traces the synthetic-drug definition to that enactment, and the listed compounds include mitragynine and 7-hydroxymitragynine.
• 2013Public Law 196-2013 amended the synthetic-drug definition and added dedicated synthetic-drug possession and dealing provisions.
• 2014Indiana revised its criminal classifications and penalties through the broader criminal-code revision process while retaining the kratom alkaloids in the synthetic-drug framework.
• July 1, 2019Indiana repealed the dedicated synthetic-drug dealing and possession sections and incorporated synthetic drugs into the general Schedule I offense structure.
• 2023HB1500 proposed a regulated market for qualifying kratom products, including product specifications and restrictions, but the proposal did not become law.
• 2025The codified synthetic-drug definition was amended for other listed compounds while mitragynine and 7-hydroxymitragynine remained in the definition.
• July 21, 2026The 2026 Indiana Code continues to classify synthetic drugs as Schedule I and continues to name both kratom alkaloids in the synthetic-drug definition.

The 2012 source history is important because Indiana's restriction did not begin as a modern 7-OH-only measure. Both mitragynine and 7-hydroxymitragynine appear in the statutory list. Traditional leaf products therefore remain affected alongside concentrated formats.

Public Law 119-2019 reorganized the offense structure. The dedicated sections for synthetic-drug dealing and possession were repealed, while the Schedule I law expressly incorporated synthetic drugs as defined in section 35-31.5-2-321. Reading only the repealed section numbers would produce the wrong result; the named compounds remained controlled through the general provisions.

HB1500 in 2023 would have created a different approach. Its proposed definition described a qualifying kratom product derived from leaf or extract, imposed residual-solvent and alkaloid specifications, excluded synthetic alkaloids and other controlled substances, and set distribution requirements. The bill advanced in the House but did not complete enactment, so its proposed lawful-product category never became current Indiana law.

No enacted 2025 or 2026 measure removed mitragynine or 7-hydroxymitragynine from section 35-31.5-2-321 before the verification date. A proposal to regulate kratom cannot reopen sales unless it passes both chambers, receives the required final approval, and reaches its effective date.

Which kratom product formats are restricted?

Indiana's legal classification follows the chemical contents of the product. Since ordinary kratom contains mitragynine, changing the physical form does not create a reliable consumer-retail exception.

• Whole, crushed, or dried leaf: unavailable for ordinary consumer sale because naturally occurring mitragynine is named in the synthetic-drug definition.
• Loose powder: restricted for the same reason; grinding the leaf does not remove its alkaloids.
• Capsules: restricted when the capsule fill contains kratom or its named alkaloids.
• Extract powders and liquids: restricted when they contain mitragynine, 7-hydroxymitragynine, or another controlled constituent.
• MIT tablets: directly implicated because mitragynine is listed by name.
• 7-OH products: directly implicated because 7-hydroxymitragynine is separately listed by name.
• Samples, gifts, and promotional products: unavailable because delivery does not become lawful when no purchase price is charged.
• Bulk products: unavailable, and larger quantities may carry significantly greater criminal exposure under the quantity-based dealing statute.

A laboratory report does not create an Indiana exemption. Testing can identify the product's contents, but it cannot remove mitragynine or 7-hydroxymitragynine from the statutory list. Likewise, a package bearing warnings, age restrictions, ingredient declarations, or a batch number does not convert a Schedule I substance into an ordinary retail product.

A low concentration also does not establish a safe harbor. Indiana does not set a permitted kratom threshold comparable to states that regulate the percentage of 7-hydroxymitragynine in an alkaloid fraction. The current code names the compounds without creating an ordinary consumer concentration exception.

Transporting kratom into Indiana

The restriction matters to people crossing into Indiana as well as to businesses shipping there. A product purchased legally in another state does not keep that status after entering Indiana. The destination state's possession and controlled-substance rules apply within Indiana.

Original packaging, a receipt from another state, or proof that the buyer is an adult does not create a consumer exemption. Anyone dealing with an individual legal situation should consult a qualified Indiana attorney rather than relying on a retailer's availability elsewhere.

Does Kratom Paradise ship to Indiana?

No. Kratom Paradise does not accept orders for Indiana delivery. There is no delivery estimate because Indiana is unavailable for the kratom catalog.

Section 35-48-4-2 expressly addresses delivery of Schedule I substances. A shipment initiated from outside Indiana does not become an ordinary lawful retail transaction merely because a common carrier handles the package. The commercial decision still involves delivering a product containing a substance Indiana places in Schedule I.

The restriction applies across the catalog, including leaf powder, capsules, extract powder, tablets, samples, replacements, promotional items, and bulk formats. Splitting a larger order into smaller packages does not create eligibility, and using a different product description does not change the ingredients.

Adult-signature service and identity verification do not solve the underlying issue. Those tools can enforce an age rule in a state that permits adult sales, but Indiana does not provide an ordinary adult kratom-sales pathway. An adult recipient remains ineligible for direct-to-consumer shipment.

Shipping should be reconsidered only after a final enacted law removes the named alkaloids from the controlled framework or creates a clear operative exception for qualifying kratom products. An introduced bill, committee hearing, press statement, or proposed effective date is not enough to accept Indiana orders.

Official Indiana sources reviewed

• 2026 Indiana Code, Title 35
  The current official code containing sections 35-31.5-2-321, 35-48-2-4, 35-48-4-2, and 35-48-4-7.
• Indiana Code downloads
  The General Assembly's official downloadable compilation of the current Indiana Code.
• Indiana Code Title 35 compilation
  An official state-hosted Title 35 compilation showing the named mitragynine and 7-hydroxymitragynine entries and their statutory placement.
• Indiana General Assembly: HB1500
  Official legislative record for the 2023 proposal to establish a regulated category of qualifying kratom products.
• Indiana General Assembly
  The official source confirming that the 2026 Indiana Code is updated through the 2026 regular session.

Last reviewed: Verified July 21, 2026. Statewide information only; not legal advice.